Leerink Swann restated their outperform rating on shares of AC Immune Ltd (NASDAQ:ACIU) in a report issued on Saturday morning.
A number of other equities analysts have also recently commented on the company. Jefferies Group assumed coverage on AC Immune in a report on Tuesday, October 18th. They set a buy rating and a $25.00 target price for the company. Credit Suisse Group AG assumed coverage on AC Immune in a report on Tuesday, October 18th. They set an outperform rating and a $18.00 target price for the company.
Shares of AC Immune (NASDAQ:ACIU) traded up 9.37% during midday trading on Friday, hitting $12.61. The stock had a trading volume of 269,075 shares. AC Immune has a one year low of $10.36 and a one year high of $19.97. The stock’s market cap is $624.74 million. The firm has a 50 day moving average price of $14.16 and a 200 day moving average price of $14.83.